Clinical and radiographic assessment of peripheral joints in controlled acromegaly
Purpose Acromegalic arthropathy is a well-known phenomenon, occurring in most patients regardless of disease status. To date, solely hips, knees, hands, and spinal joints have been radiographically assessed. Therefore, this study aimed to assess the prevalence of joint symptoms and radiographic oste...
Gespeichert in:
Veröffentlicht in: | Pituitary 2022-08, Vol.25 (4), p.622-635 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 635 |
---|---|
container_issue | 4 |
container_start_page | 622 |
container_title | Pituitary |
container_volume | 25 |
creator | Pelsma, Iris C. M. Kroon, Herman M. van Trigt, Victoria R. Pereira, Alberto M. Kloppenburg, Margreet Biermasz, Nienke R. Claessen, Kim M. J. A. |
description | Purpose
Acromegalic arthropathy is a well-known phenomenon, occurring in most patients regardless of disease status. To date, solely hips, knees, hands, and spinal joints have been radiographically assessed. Therefore, this study aimed to assess the prevalence of joint symptoms and radiographic osteoarthritis (OA) of new, and established peripheral joint sites in well-controlled acromegaly.
Methods
Fifty-one acromegaly patients (56% female, mean age 64 ± 12 years) in long-term remission for 18.3 years (median, IQR 7.2–25.4) were included. Nineteen patients currently received pharmacological treatment. Self-reported joint complaints were assessed using standardized interviews. Self-reported disability of the upper and lower limbs, and health-related quality of life (HR-QoL) were evaluated using validated questionnaires. Radiographic OA [defined as Kellgren & Lawrence (KL) ≥ 2] was scored using (modified) KL methods.
Results
Radiographic signs of OA were present in 46 patients (90.2%) with ≥ 2 joints affected in virtually all of these patients (N = 44; 95.7%). Radiographic MTP1 OA was as prevalent as radiographic knee OA (N = 26, 51.0%), and radiographic glenohumeral OA was similarly prevalent as hip OA [N = 21 (41.2%)
vs.
N = 24 (47.1%)]. Risk factors for radiographic glenohumeral OA were higher pre-treatment IGF-1 levels [OR 1.06 (1.01–1.12),
P
= 0.021], and current pharmacological treatment [OR 5.01 (1.03–24.54),
P
= 0.047], whereas no risk factors for MTP1 joint OA could be identified.
Conclusion
Similar to previously-assessed peripheral joints, clinical and radiographic arthropathy of the shoulder and feet were prevalent in controlled acromegaly. Further studies on adequate management strategies of acromegalic arthropathy are needed. |
doi_str_mv | 10.1007/s11102-022-01233-z |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9345810</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2697194315</sourcerecordid><originalsourceid>FETCH-LOGICAL-c451t-c95707d20fd36b5891b3feb9b51cef876dec5b1a0117d1a3c66e51132041cd0e3</originalsourceid><addsrcrecordid>eNp9kU9r3DAQxUVpaf60XyAnQy-9ONFoLGt9KZQlbQOBQmkhNyFL410ttuRK3kDy6atkQ0p66EGMQL_3eJrH2Bnwc-BcXWQA4KLmohwQiPX9K3YMUmGtGo6vyx1XbY0N3Byxk5x3nBcZNm_ZEUolWgA8Zj_Wow_emrEywVXJOB83ycxbbyuTM-U8UViqOFQzJT9vKRVyF31YcuVDZWNYUhxHcpWxKU60MePdO_ZmMGOm90_zlP36cvlz_a2-_v71av35uraNhKW2nVRcOcEHh20vVx30OFDf9RIsDSvVOrKyB8MBlAODtm1JlsyCN2AdJzxlnw6-876fyNkStKTTc_KTSXc6Gq9fvgS_1Zt4qzts5Ap4Mfj4ZJDi7z3lRU8-WxpHEyjusxat6gQqULKgH_5Bd3GfQvleoToFXYPwQIkDVXaRc6LhOQxw_VCZPlSmS2X6sTJ9X0R4EOUChw2lv9b_Uf0BLXqZ2w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2697194315</pqid></control><display><type>article</type><title>Clinical and radiographic assessment of peripheral joints in controlled acromegaly</title><source>SpringerLink Journals - AutoHoldings</source><creator>Pelsma, Iris C. M. ; Kroon, Herman M. ; van Trigt, Victoria R. ; Pereira, Alberto M. ; Kloppenburg, Margreet ; Biermasz, Nienke R. ; Claessen, Kim M. J. A.</creator><creatorcontrib>Pelsma, Iris C. M. ; Kroon, Herman M. ; van Trigt, Victoria R. ; Pereira, Alberto M. ; Kloppenburg, Margreet ; Biermasz, Nienke R. ; Claessen, Kim M. J. A.</creatorcontrib><description>Purpose
Acromegalic arthropathy is a well-known phenomenon, occurring in most patients regardless of disease status. To date, solely hips, knees, hands, and spinal joints have been radiographically assessed. Therefore, this study aimed to assess the prevalence of joint symptoms and radiographic osteoarthritis (OA) of new, and established peripheral joint sites in well-controlled acromegaly.
Methods
Fifty-one acromegaly patients (56% female, mean age 64 ± 12 years) in long-term remission for 18.3 years (median, IQR 7.2–25.4) were included. Nineteen patients currently received pharmacological treatment. Self-reported joint complaints were assessed using standardized interviews. Self-reported disability of the upper and lower limbs, and health-related quality of life (HR-QoL) were evaluated using validated questionnaires. Radiographic OA [defined as Kellgren & Lawrence (KL) ≥ 2] was scored using (modified) KL methods.
Results
Radiographic signs of OA were present in 46 patients (90.2%) with ≥ 2 joints affected in virtually all of these patients (N = 44; 95.7%). Radiographic MTP1 OA was as prevalent as radiographic knee OA (N = 26, 51.0%), and radiographic glenohumeral OA was similarly prevalent as hip OA [N = 21 (41.2%)
vs.
N = 24 (47.1%)]. Risk factors for radiographic glenohumeral OA were higher pre-treatment IGF-1 levels [OR 1.06 (1.01–1.12),
P
= 0.021], and current pharmacological treatment [OR 5.01 (1.03–24.54),
P
= 0.047], whereas no risk factors for MTP1 joint OA could be identified.
Conclusion
Similar to previously-assessed peripheral joints, clinical and radiographic arthropathy of the shoulder and feet were prevalent in controlled acromegaly. Further studies on adequate management strategies of acromegalic arthropathy are needed.</description><identifier>ISSN: 1386-341X</identifier><identifier>EISSN: 1573-7403</identifier><identifier>DOI: 10.1007/s11102-022-01233-z</identifier><identifier>PMID: 35726113</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Acromegaly ; Arthritis ; Cross-sectional studies ; Disease control ; Drug therapy ; Endocrinology ; Growth hormones ; Hip ; Hormone replacement therapy ; Human Physiology ; Insulin ; Insulin-like growth factor I ; Insulin-like growth factors ; Knee ; Medicine ; Medicine & Public Health ; Metabolism ; Osteoarthritis ; Patients ; Quality of life ; Questionnaires ; Remission ; Remission (Medicine) ; Risk factors</subject><ispartof>Pituitary, 2022-08, Vol.25 (4), p.622-635</ispartof><rights>The Author(s) 2022</rights><rights>The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c451t-c95707d20fd36b5891b3feb9b51cef876dec5b1a0117d1a3c66e51132041cd0e3</citedby><cites>FETCH-LOGICAL-c451t-c95707d20fd36b5891b3feb9b51cef876dec5b1a0117d1a3c66e51132041cd0e3</cites><orcidid>0000-0003-4956-4037</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s11102-022-01233-z$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s11102-022-01233-z$$EHTML$$P50$$Gspringer$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,27903,27904,41467,42536,51297</link.rule.ids></links><search><creatorcontrib>Pelsma, Iris C. M.</creatorcontrib><creatorcontrib>Kroon, Herman M.</creatorcontrib><creatorcontrib>van Trigt, Victoria R.</creatorcontrib><creatorcontrib>Pereira, Alberto M.</creatorcontrib><creatorcontrib>Kloppenburg, Margreet</creatorcontrib><creatorcontrib>Biermasz, Nienke R.</creatorcontrib><creatorcontrib>Claessen, Kim M. J. A.</creatorcontrib><title>Clinical and radiographic assessment of peripheral joints in controlled acromegaly</title><title>Pituitary</title><addtitle>Pituitary</addtitle><description>Purpose
Acromegalic arthropathy is a well-known phenomenon, occurring in most patients regardless of disease status. To date, solely hips, knees, hands, and spinal joints have been radiographically assessed. Therefore, this study aimed to assess the prevalence of joint symptoms and radiographic osteoarthritis (OA) of new, and established peripheral joint sites in well-controlled acromegaly.
Methods
Fifty-one acromegaly patients (56% female, mean age 64 ± 12 years) in long-term remission for 18.3 years (median, IQR 7.2–25.4) were included. Nineteen patients currently received pharmacological treatment. Self-reported joint complaints were assessed using standardized interviews. Self-reported disability of the upper and lower limbs, and health-related quality of life (HR-QoL) were evaluated using validated questionnaires. Radiographic OA [defined as Kellgren & Lawrence (KL) ≥ 2] was scored using (modified) KL methods.
Results
Radiographic signs of OA were present in 46 patients (90.2%) with ≥ 2 joints affected in virtually all of these patients (N = 44; 95.7%). Radiographic MTP1 OA was as prevalent as radiographic knee OA (N = 26, 51.0%), and radiographic glenohumeral OA was similarly prevalent as hip OA [N = 21 (41.2%)
vs.
N = 24 (47.1%)]. Risk factors for radiographic glenohumeral OA were higher pre-treatment IGF-1 levels [OR 1.06 (1.01–1.12),
P
= 0.021], and current pharmacological treatment [OR 5.01 (1.03–24.54),
P
= 0.047], whereas no risk factors for MTP1 joint OA could be identified.
Conclusion
Similar to previously-assessed peripheral joints, clinical and radiographic arthropathy of the shoulder and feet were prevalent in controlled acromegaly. Further studies on adequate management strategies of acromegalic arthropathy are needed.</description><subject>Acromegaly</subject><subject>Arthritis</subject><subject>Cross-sectional studies</subject><subject>Disease control</subject><subject>Drug therapy</subject><subject>Endocrinology</subject><subject>Growth hormones</subject><subject>Hip</subject><subject>Hormone replacement therapy</subject><subject>Human Physiology</subject><subject>Insulin</subject><subject>Insulin-like growth factor I</subject><subject>Insulin-like growth factors</subject><subject>Knee</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Metabolism</subject><subject>Osteoarthritis</subject><subject>Patients</subject><subject>Quality of life</subject><subject>Questionnaires</subject><subject>Remission</subject><subject>Remission (Medicine)</subject><subject>Risk factors</subject><issn>1386-341X</issn><issn>1573-7403</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp9kU9r3DAQxUVpaf60XyAnQy-9ONFoLGt9KZQlbQOBQmkhNyFL410ttuRK3kDy6atkQ0p66EGMQL_3eJrH2Bnwc-BcXWQA4KLmohwQiPX9K3YMUmGtGo6vyx1XbY0N3Byxk5x3nBcZNm_ZEUolWgA8Zj_Wow_emrEywVXJOB83ycxbbyuTM-U8UViqOFQzJT9vKRVyF31YcuVDZWNYUhxHcpWxKU60MePdO_ZmMGOm90_zlP36cvlz_a2-_v71av35uraNhKW2nVRcOcEHh20vVx30OFDf9RIsDSvVOrKyB8MBlAODtm1JlsyCN2AdJzxlnw6-876fyNkStKTTc_KTSXc6Gq9fvgS_1Zt4qzts5Ap4Mfj4ZJDi7z3lRU8-WxpHEyjusxat6gQqULKgH_5Bd3GfQvleoToFXYPwQIkDVXaRc6LhOQxw_VCZPlSmS2X6sTJ9X0R4EOUChw2lv9b_Uf0BLXqZ2w</recordid><startdate>20220801</startdate><enddate>20220801</enddate><creator>Pelsma, Iris C. M.</creator><creator>Kroon, Herman M.</creator><creator>van Trigt, Victoria R.</creator><creator>Pereira, Alberto M.</creator><creator>Kloppenburg, Margreet</creator><creator>Biermasz, Nienke R.</creator><creator>Claessen, Kim M. J. A.</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-4956-4037</orcidid></search><sort><creationdate>20220801</creationdate><title>Clinical and radiographic assessment of peripheral joints in controlled acromegaly</title><author>Pelsma, Iris C. M. ; Kroon, Herman M. ; van Trigt, Victoria R. ; Pereira, Alberto M. ; Kloppenburg, Margreet ; Biermasz, Nienke R. ; Claessen, Kim M. J. A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c451t-c95707d20fd36b5891b3feb9b51cef876dec5b1a0117d1a3c66e51132041cd0e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Acromegaly</topic><topic>Arthritis</topic><topic>Cross-sectional studies</topic><topic>Disease control</topic><topic>Drug therapy</topic><topic>Endocrinology</topic><topic>Growth hormones</topic><topic>Hip</topic><topic>Hormone replacement therapy</topic><topic>Human Physiology</topic><topic>Insulin</topic><topic>Insulin-like growth factor I</topic><topic>Insulin-like growth factors</topic><topic>Knee</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Metabolism</topic><topic>Osteoarthritis</topic><topic>Patients</topic><topic>Quality of life</topic><topic>Questionnaires</topic><topic>Remission</topic><topic>Remission (Medicine)</topic><topic>Risk factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pelsma, Iris C. M.</creatorcontrib><creatorcontrib>Kroon, Herman M.</creatorcontrib><creatorcontrib>van Trigt, Victoria R.</creatorcontrib><creatorcontrib>Pereira, Alberto M.</creatorcontrib><creatorcontrib>Kloppenburg, Margreet</creatorcontrib><creatorcontrib>Biermasz, Nienke R.</creatorcontrib><creatorcontrib>Claessen, Kim M. J. A.</creatorcontrib><collection>Springer Nature OA/Free Journals</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Pituitary</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pelsma, Iris C. M.</au><au>Kroon, Herman M.</au><au>van Trigt, Victoria R.</au><au>Pereira, Alberto M.</au><au>Kloppenburg, Margreet</au><au>Biermasz, Nienke R.</au><au>Claessen, Kim M. J. A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical and radiographic assessment of peripheral joints in controlled acromegaly</atitle><jtitle>Pituitary</jtitle><stitle>Pituitary</stitle><date>2022-08-01</date><risdate>2022</risdate><volume>25</volume><issue>4</issue><spage>622</spage><epage>635</epage><pages>622-635</pages><issn>1386-341X</issn><eissn>1573-7403</eissn><abstract>Purpose
Acromegalic arthropathy is a well-known phenomenon, occurring in most patients regardless of disease status. To date, solely hips, knees, hands, and spinal joints have been radiographically assessed. Therefore, this study aimed to assess the prevalence of joint symptoms and radiographic osteoarthritis (OA) of new, and established peripheral joint sites in well-controlled acromegaly.
Methods
Fifty-one acromegaly patients (56% female, mean age 64 ± 12 years) in long-term remission for 18.3 years (median, IQR 7.2–25.4) were included. Nineteen patients currently received pharmacological treatment. Self-reported joint complaints were assessed using standardized interviews. Self-reported disability of the upper and lower limbs, and health-related quality of life (HR-QoL) were evaluated using validated questionnaires. Radiographic OA [defined as Kellgren & Lawrence (KL) ≥ 2] was scored using (modified) KL methods.
Results
Radiographic signs of OA were present in 46 patients (90.2%) with ≥ 2 joints affected in virtually all of these patients (N = 44; 95.7%). Radiographic MTP1 OA was as prevalent as radiographic knee OA (N = 26, 51.0%), and radiographic glenohumeral OA was similarly prevalent as hip OA [N = 21 (41.2%)
vs.
N = 24 (47.1%)]. Risk factors for radiographic glenohumeral OA were higher pre-treatment IGF-1 levels [OR 1.06 (1.01–1.12),
P
= 0.021], and current pharmacological treatment [OR 5.01 (1.03–24.54),
P
= 0.047], whereas no risk factors for MTP1 joint OA could be identified.
Conclusion
Similar to previously-assessed peripheral joints, clinical and radiographic arthropathy of the shoulder and feet were prevalent in controlled acromegaly. Further studies on adequate management strategies of acromegalic arthropathy are needed.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>35726113</pmid><doi>10.1007/s11102-022-01233-z</doi><tpages>14</tpages><orcidid>https://orcid.org/0000-0003-4956-4037</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1386-341X |
ispartof | Pituitary, 2022-08, Vol.25 (4), p.622-635 |
issn | 1386-341X 1573-7403 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9345810 |
source | SpringerLink Journals - AutoHoldings |
subjects | Acromegaly Arthritis Cross-sectional studies Disease control Drug therapy Endocrinology Growth hormones Hip Hormone replacement therapy Human Physiology Insulin Insulin-like growth factor I Insulin-like growth factors Knee Medicine Medicine & Public Health Metabolism Osteoarthritis Patients Quality of life Questionnaires Remission Remission (Medicine) Risk factors |
title | Clinical and radiographic assessment of peripheral joints in controlled acromegaly |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T18%3A06%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20and%20radiographic%20assessment%20of%20peripheral%20joints%20in%20controlled%20acromegaly&rft.jtitle=Pituitary&rft.au=Pelsma,%20Iris%20C.%20M.&rft.date=2022-08-01&rft.volume=25&rft.issue=4&rft.spage=622&rft.epage=635&rft.pages=622-635&rft.issn=1386-341X&rft.eissn=1573-7403&rft_id=info:doi/10.1007/s11102-022-01233-z&rft_dat=%3Cproquest_pubme%3E2697194315%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2697194315&rft_id=info:pmid/35726113&rfr_iscdi=true |